Recent studies have identified polymorphisms in TGF-β1, proprotein convertase subtilisin/kexin type 6 (PCSK6), and protein kinase N2 (PKN2) as critical determinants of disease progression and survival outcomes in IPF. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.